Darmadji T, Pikir B S, Yogiarto M, Saleh M
Ann Acad Med Singap. 1981 Oct;10(4 Suppl):21-4.
The antihypertensive effect of acebutolol 400 mg and hydrochlorothiazide 25 mg in combination have been assessed in 22 patients with mild, moderate and severe hypertension. In the supine position, blood pressure went down from an average of 190/116 mm Hg to 147/91 mm Hg after treatment, while in the standing position, blood pressure went down from an average of 188/117 mm Hg to 143/94 mm Hg. Age, sex and duration of hypertension have no significant influence upon the antihypertensive effect of this combination. Good results were obtained in 68% of the patients, fair results in 23% and poor results in another 9%. Compared with the use of acebutolol alone, its combination with hydrochlorothiazide showed better results. In mild hypertension good results increased from 75% after acebutolol only to 100% after this combination. In moderate hypertension the percentage of good results increases from 47% to 60% and in severe hypertension good results increased from 50% to 67%. Increase of decrease in heart rate had no relation to the antihypertensive effect of this combination.
对22例轻度、中度和重度高血压患者评估了醋丁洛尔400毫克与氢氯噻嗪25毫克联合使用的降压效果。仰卧位时,治疗后血压从平均190/116毫米汞柱降至147/91毫米汞柱,而站立位时,血压从平均188/117毫米汞柱降至143/94毫米汞柱。年龄、性别和高血压病程对该联合用药的降压效果无显著影响。68%的患者效果良好,23%的患者效果尚可,另有9%的患者效果不佳。与单独使用醋丁洛尔相比,其与氢氯噻嗪联合使用效果更佳。在轻度高血压患者中,良好效果从仅使用醋丁洛尔后的75%增至联合用药后的100%。在中度高血压患者中,良好效果的百分比从47%增至60%,在重度高血压患者中,良好效果从50%增至67%。心率的增加或降低与该联合用药的降压效果无关。